<VariationArchive VariationID="17725" VariationName="NM_002101.4(GYPC):c.107_190del" VariationType="Deletion" Accession="VCV000017725" Version="3" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="1" DateLastUpdated="2024-07-29" DateCreated="2017-01-23" MostRecentSubmission="2017-01-23">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="32764" VariationID="17725">
      <GeneList>
        <Gene Symbol="GYPC" FullName="glycophorin C (Gerbich blood group)" GeneID="2995" HGNC_ID="HGNC:4704" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>2q14.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="126656158" stop="126696667" display_start="126656158" display_stop="126696667" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="127413510" stop="127454250" display_start="127413510" display_stop="127454250" Strand="+" />
          </Location>
          <OMIM>110750</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_002101.4(GYPC):c.107_190del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>2q14.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="126693861" stop="126693944" display_start="126693861" display_stop="126693944" variantLength="84" positionVCF="126693860" referenceAlleleVCF="ACAGAGCCTGATCCAGGGATGTCTGGATGGCCGGATGGCAGAATGGAGACCTCCACCCCCACCATAATGGACATTGTCGTCATTG" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="127451437" stop="127451520" display_start="127451437" display_stop="127451520" variantLength="84" positionVCF="127451436" referenceAlleleVCF="ACAGAGCCTGATCCAGGGATGTCTGGATGGCCGGATGGCAGAATGGAGACCTCCACCCCCACCATAATGGACATTGTCGTCATTG" alternateAlleleVCF="A" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.11" sequenceAccession="NC_000002" sequenceVersion="11" change="g.127451440_127451523del" Assembly="GRCh37">
            <Expression>NC_000002.11:g.127451440_127451523del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.12" sequenceAccession="NC_000002" sequenceVersion="12" change="g.126693864_126693947del" Assembly="GRCh38">
            <Expression>NC_000002.12:g.126693864_126693947del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007479.1" sequenceAccession="NG_007479" sequenceVersion="1" change="g.42757_42840del">
            <Expression>NG_007479.1:g.42757_42840del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_813" sequenceAccession="LRG_813">
            <Expression>LRG_813:g.42757_42840del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA127348" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="110750.0002" DB="OMIM" />
      </XRefList>
      <FunctionalConsequence Value="exon loss">
        <XRef ID="0381" DB="Variation Ontology" />
        <Comment DataSource="NCBI curation" Type="public">Loss of exon 3 from GYPC.</Comment>
      </FunctionalConsequence>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_002101.4(GYPC):c.107_190del AND Glycophorin c, gerbich variant" Accession="RCV000019298" Version="34">
        <ClassifiedConditionList TraitSetID="5822">
          <ClassifiedCondition>Glycophorin c, gerbich variant</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2003-01-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_002101.4(GYPC):c.107_190del AND Malaria, resistance to" Accession="RCV000019299" Version="39">
        <ClassifiedConditionList TraitSetID="1232">
          <ClassifiedCondition DB="MedGen" ID="C2720293">Malaria, resistance to</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2003-01-01" SubmissionCount="1">protective</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2003-01-01" NumberOfSubmissions="2" NumberOfSubmitters="1" DateCreated="2017-01-23" MostRecentSubmission="2017-01-23">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic; protective</Description>
        <Citation Type="general">
          <ID Source="PubMed">11719395</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">12469115</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">1991173</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21061946</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">5011657</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">8157284</ID>
        </Citation>
        <DescriptionHistory Dated="2022-03-16">
          <Description>Pathogenic, protective</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="1232" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="10078" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Malaria, resistance to</ElementValue>
              </Name>
              <XRef ID="C2720293" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="5822" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="12848" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Glycophorin c, gerbich variant</ElementValue>
              </Name>
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="39587" SubmissionDate="2017-01-18" DateLastUpdated="2017-01-23" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="110750.0002_GERBICH BLOOD GROUP SYSTEM, GERBICH PHENOTYPE" title="GYPC, 84-BP DEL, EX3_GERBICH BLOOD GROUP SYSTEM, GERBICH PHENOTYPE" />
        <ClinVarAccession Accession="SCV000039587" DateUpdated="2017-01-23" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2003-01-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In the Gerbich phenotype of the Gerbich blood group system (616089), Chang et al. (1991) identified deletion of the 84-bp exon 3 of the GYPC gene.</Attribute>
              <Citation>
                <ID Source="PubMed">1991173</ID>
              </Citation>
              <XRef DB="OMIM" ID="616089" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Deletion of exon 3 in the GYPC gene has been found in Melanesians; this alteration changes the serologic phenotype of the Ge blood group system, resulting in Ge negativity (Booth and McLoughlin, 1972; Serjeantson et al., 1994). The GYPC ex3del allele reaches a high frequency (46.5%) in coastal areas of Papua New Guinea where malaria (611162) is hyperendemic (Patel et al., 2001). The Plasmodium falciparum erythrocyte-binding antigen-140 (EBA140, also known as BAEBL) binds with high affinity to the surface of human erythrocytes. Maier et al. (2003) showed that the receptor for EBA140 is glycophorin C and that this interaction mediates a principal P. falciparum invasion pathway into human erythrocytes. EBA140 does not bind to GYPC in Ge-negative erythrocytes, nor can P. falciparum invade such cells using this invasion pathway. This provides compelling evidence that Ge negativity has arisen in Melanesian populations through natural selection by severe malaria.</Attribute>
              <Citation>
                <ID Source="PubMed">5011657</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">8157284</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">11719395</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">12469115</ID>
              </Citation>
              <XRef DB="OMIM" ID="611162" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Using archival blood samples from children less than 6 years old in a malaria-endemic district of Papua New Guinea, Tavul et al. (2008) performed a case-control study to investigate the role of the GYPC exon 3 deletion in protection against severe malarial anemia (SMA). They confirmed the high frequency of the exon 3 deletion in this population, but they found no association between the polymorphism and protection from SMA.</Attribute>
              <Citation>
                <ID Source="PubMed">21061946</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GYPC" />
          </GeneList>
          <Name>GYPC, 84-BP DEL, EX3</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">84-BP DEL, EX3</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="110750.0002" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">GERBICH BLOOD GROUP SYSTEM, GERBICH PHENOTYPE</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="39588" SubmissionDate="2017-01-18" DateLastUpdated="2017-01-23" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="110750.0002_MALARIA, RESISTANCE TO" title="GYPC, 84-BP DEL, EX3_MALARIA, RESISTANCE TO" />
        <ClinVarAccession Accession="SCV000039588" DateUpdated="2017-01-23" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2003-01-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>protective</GermlineClassification>
        </Classification>
        <Assertion>variation to included disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In the Gerbich phenotype of the Gerbich blood group system (616089), Chang et al. (1991) identified deletion of the 84-bp exon 3 of the GYPC gene.</Attribute>
              <Citation>
                <ID Source="PubMed">1991173</ID>
              </Citation>
              <XRef DB="OMIM" ID="616089" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Deletion of exon 3 in the GYPC gene has been found in Melanesians; this alteration changes the serologic phenotype of the Ge blood group system, resulting in Ge negativity (Booth and McLoughlin, 1972; Serjeantson et al., 1994). The GYPC ex3del allele reaches a high frequency (46.5%) in coastal areas of Papua New Guinea where malaria (611162) is hyperendemic (Patel et al., 2001). The Plasmodium falciparum erythrocyte-binding antigen-140 (EBA140, also known as BAEBL) binds with high affinity to the surface of human erythrocytes. Maier et al. (2003) showed that the receptor for EBA140 is glycophorin C and that this interaction mediates a principal P. falciparum invasion pathway into human erythrocytes. EBA140 does not bind to GYPC in Ge-negative erythrocytes, nor can P. falciparum invade such cells using this invasion pathway. This provides compelling evidence that Ge negativity has arisen in Melanesian populations through natural selection by severe malaria.</Attribute>
              <Citation>
                <ID Source="PubMed">5011657</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">8157284</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">11719395</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">12469115</ID>
              </Citation>
              <XRef DB="OMIM" ID="611162" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Using archival blood samples from children less than 6 years old in a malaria-endemic district of Papua New Guinea, Tavul et al. (2008) performed a case-control study to investigate the role of the GYPC exon 3 deletion in protection against severe malarial anemia (SMA). They confirmed the high frequency of the exon 3 deletion in this population, but they found no association between the polymorphism and protection from SMA.</Attribute>
              <Citation>
                <ID Source="PubMed">21061946</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GYPC" />
          </GeneList>
          <Name>GYPC, 84-BP DEL, EX3</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">84-BP DEL, EX3</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="110750.0002" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="included">MALARIA, RESISTANCE TO</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="39588" TraitType="Disease" MappingType="Name" MappingValue="MALARIA, RESISTANCE TO" MappingRef="Alternate">
        <MedGen CUI="C2720293" Name="Malaria, resistance to" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="39587" TraitType="Disease" MappingType="Name" MappingValue="GERBICH BLOOD GROUP SYSTEM, GERBICH PHENOTYPE" MappingRef="Preferred">
        <MedGen CUI="C4015913" Name="Glycophorin c, gerbich variant" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

